AENDO June 39/6

Ghigo, E., G. Aimaretti, M. Maccario, G. Fanciulli, E. Arvat, F. Minuto, G. Giordano, G. Delitala, and F. Camanni. Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am. J. Physiol. 276 (Endocrinol. Metab. 39): E1009–E1013, 1999.—The aim of our study was to define the dose-response effect of a short-term treatment with different recombinant human growth hormone (rhGH) doses (1.25, 2.5, 5.0, 10.0, and 20.0 μg·kg21 ·day21 for 4 days) on insulin-like growth factor I (IGF-I) and insulin-like growth factor-binding protein (IGFBP)-3 levels in 21 normal young adults of both sexes. The dose of 1.25 μg/kg rhGH did not modify IGF-I levels. The dose of 2.5 μg/kg rhGH significantly increased IGF-I levels in men (P , 0.05) but not in women, whereas the higher doses increased IGF-I levels in both sexes (P , 0.002). IGFBP-3 levels were not modified by 1.25 or 2.5 μg/kg rhGH in either sex. On the other hand, 5.0 μg/kg increased IGFBP-3 levels in men (P , 0.05) but not in women, whereas the higher doses increased IGFBP-3 levels similarly in both sexes (P , 0.02). In conclusion, our results demonstrate that IGF-I and IGFBP-3 responses to rhGH are dose and sex dependent. However, IGFBP-3 is less sensitive than IGF-I to rhGH stimulation.